On June 5, Health 160 rose 6.71% in regular trading, trading at 15.83 HKD/share, with trading volume of HKD 239 million. The stock benefited from a broad rally in Hong Kong-listed AI medical concept stocks and continued momentum from key business milestones.

On the news front, Frost & Sullivan recently certified Health 160 as the No.1 AI hospital operations service provider by hospital contract count and implementation scenarios. The company disclosed that as of late April, it had secured operational cooperation with 120 public medical institutions, of which 80.8% are tier-3 or above hospitals and 66 are top-tier tier-3A hospitals. A benchmark case demonstrated online GMV monthly compound growth of 155.7% for non-medical-insurance self-pay items at a partnered tier-3A hospital. On the same day, the broader AI medical sector saw strong gains, with multiple peers posting significant advances, further amplifying bullish sentiment toward Health 160.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)